Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply.
N Engl J Med
; 386(18): 1768, 2022 05 05.
Article
in En
| MEDLINE
| ID: mdl-35507493
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Neoplasms
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
N Engl J Med
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: